The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors BeiGene AUS Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type Designation or determination (1) Designation or determination (1) Prescription medicine registration (1) Prescription medicine registration (1) Date 2023 (2) (-) 2023 (2) 2025 (1) 2025 (1) 2024 (8) 2024 (8) 2022 (3) 2022 (3) 2021 (6) 2021 (6) 2020 (1) 2020 (1) Show more Search Filters applied:2023Clear all Sponsor content2 result(s) found, displaying 1 to 2 Notice for tislelizumab (Beigene Aus Pty Ltd) 23 October 2023 Designation or determination Orphan drug BRUKINSA (Beigene Aus Pty Ltd) 1 March 2023 Prescription medicine registration Active ingredients: zanubrutinib.
Notice for tislelizumab (Beigene Aus Pty Ltd) 23 October 2023 Designation or determination Orphan drug
BRUKINSA (Beigene Aus Pty Ltd) 1 March 2023 Prescription medicine registration Active ingredients: zanubrutinib.